MiniMed Group annual return on equity
2025
2026
MiniMed Group Return on Equity (ROE) Growth & History (MMED)
MiniMed Group's return on equity was −9.60% for fiscal 2026.
View full MiniMed Group company overviewMiniMed Group annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-04-24 | −9.60% | −3.31 pp |
| 2025 | 2025-04-25 | −6.29% | — |
MiniMed Group quarterly return on equity
Q3.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2027 | 2026-07-31 | 0.00% | — |
| Q4 2026 | 2026-04-24 | −5.46% | — |
| Q3 2026 | 2026-01-31 | −3.44% | — |
| Q3 2026 | 2026-01-23 | −3.30% | — |
MiniMed Group return on equity trends
Between the periods ended 2025-04-25 and 2026-04-24, MiniMed Group's return on equity decreased from −6.29% to −9.60%, a change of −3.31 percentage points. The latest reported quarter, Q1 2027, shows 0.00%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MiniMed Group source filings ↗